Yuhan Corporation to showcase CDMO capabilities at CPHI Milan 2026

Yuhan Corporation is participating in CPHI Milan 2026, the world’s largest pharmaceutical and biotech exhibition, held in Italy from October 6 to 8. The company has established a solo booth to showcase its research and development (R&D) capabilities and commercialization expertise to global partners.

A primary focus of the exhibition is promoting the company’s Contract Development and Manufacturing Organization (CDMO) competitiveness and its high-quality Active Pharmaceutical Ingredient (API) production infrastructure. This infrastructure is supported by its subsidiary, Yuhan Chemical, and meets global cGMP standards.

Key personnel from Yuhan Corporation’s global business, R&D, and overseas sales departments are attending the event to conduct one-on-one business meetings with international pharmaceutical companies and biotechs. The company aims to leverage this event to accelerate growth momentum and expand its global CDMO orders, supporting its goal of becoming a top 50 global pharmaceutical company.